Egyptian (CASE/EGX) Growth Pharmaceuticals & Biotech Stocks

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

UPDATED Aug 08, 2026

Discover Egyptian Pharmaceuticals & Biotech Growth Stocks that are on the CASE/EGX. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
RMDA	ج.م5.77	9.3%	68.6%	ج.م11.5b	ج.م5.73	39.9	32.1%	0.7%
PHAR	ج.م130.00	34.7%	158.4%	ج.م21.9b	ج.م100.00	15.6	19.5%	1.2%
AXPH	ج.م1,259.56	4.1%	97.0%	ج.م6.3b	n/a	12.6	n/a	5.0%
CPCI	ج.م487.46	4.9%	148.5%	ج.م7.3b	n/a	14.4	n/a	3.4%
BIOC	ج.م331.44	38.2%	585.5%	ج.م27.7b	n/a	129.8	n/a	0.3%
SIPC	ج.م4.70	16.6%	32.8%	ج.م1.2b	n/a	552.3	n/a	0%
OCPH	ج.م240.00	3.7%	283.0%	ج.م5.8b	n/a	17.4	n/a	1.0%
MIPH	ج.م794.00	7.3%	233.9%	ج.م9.4b	n/a	1413.9	n/a	0.3%
NIPH	ج.م271.00	21.0%	351.8%	ج.م13.6b	n/a	56.4	n/a	0.7%
ADCI	ج.م276.47	7.7%	117.7%	ج.م3.3b	n/a	14.5	n/a	1.5%
MPCI	ج.م316.59	9.2%	195.8%	ج.م7.2b	n/a	13.9	n/a	4.2%

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
RMDA	ج.م5.77	9.3%	68.6%	ج.م11.5b	ج.م5.73	39.9	32.1%	0.7%
PHAR	ج.م130.00	34.7%	158.4%	ج.م21.9b	ج.م100.00	15.6	19.5%	1.2%
AXPH	ج.م1,259.56	4.1%	97.0%	ج.م6.3b	n/a	12.6	n/a	5.0%
CPCI	ج.م487.46	4.9%	148.5%	ج.م7.3b	n/a	14.4	n/a	3.4%
BIOC	ج.م331.44	38.2%	585.5%	ج.م27.7b	n/a	129.8	n/a	0.3%
SIPC	ج.م4.70	16.6%	32.8%	ج.م1.2b	n/a	552.3	n/a	0%
OCPH	ج.م240.00	3.7%	283.0%	ج.م5.8b	n/a	17.4	n/a	1.0%
MIPH	ج.م794.00	7.3%	233.9%	ج.م9.4b	n/a	1413.9	n/a	0.3%
NIPH	ج.م271.00	21.0%	351.8%	ج.م13.6b	n/a	56.4	n/a	0.7%
ADCI	ج.م276.47	7.7%	117.7%	ج.م3.3b	n/a	14.5	n/a	1.5%
MPCI	ج.م316.59	9.2%	195.8%	ج.م7.2b	n/a	13.9	n/a	4.2%